186 related articles for article (PubMed ID: 28242882)
1. Acute bacterial conjunctivitis - antibiotic susceptibility and resistance to commercially available topical antibiotics in Nepal.
Shrestha SP; Khadka J; Pokhrel AK; Sathian B
Nepal J Ophthalmol; 2016 Jan; 8(15):23-35. PubMed ID: 28242882
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
Marangon FB; Miller D; Muallem MS; Romano AC; Alfonso EC
Am J Ophthalmol; 2004 Mar; 137(3):453-8. PubMed ID: 15013867
[TBL] [Abstract][Full Text] [Related]
3. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
Everett SL; Kowalski RP; Karenchak LM; Landsittel D; Day R; Gordon YJ
Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
[TBL] [Abstract][Full Text] [Related]
4. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
[TBL] [Abstract][Full Text] [Related]
5. Microbiological efficacy of 3-day treatment with azithromycin 1.5% eye-drops for purulent bacterial conjunctivitis.
Denis F; Chaumeil C; Goldschmidt P; Delval L; Pouliquen P; Cochereau I; Chainier D; De Barbeyrac B
Eur J Ophthalmol; 2008; 18(6):858-68. PubMed ID: 18988154
[TBL] [Abstract][Full Text] [Related]
6. Short term oral cefixime therapy for treatment of bacterial conjunctivitis.
Wald ER; Greenberg D; Hoberman A
Pediatr Infect Dis J; 2001 Nov; 20(11):1039-42. PubMed ID: 11734708
[TBL] [Abstract][Full Text] [Related]
7. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data.
Kowalski RP; Yates KA; Romanowski EG; Karenchak LM; Mah FS; Gordon YJ
Ophthalmology; 2005 Nov; 112(11):1987. PubMed ID: 16183128
[TBL] [Abstract][Full Text] [Related]
8. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years.
Chalita MR; Höfling-Lima AL; Paranhos A; Schor P; Belfort R
Am J Ophthalmol; 2004 Jan; 137(1):43-51. PubMed ID: 14700643
[TBL] [Abstract][Full Text] [Related]
9. [The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva].
Koss MJ; Eder M; Blumenkranz MS; Klauss V; Ta CN; de Kaspar HM
Ophthalmologe; 2007 Jan; 104(1):21-7. PubMed ID: 17160378
[TBL] [Abstract][Full Text] [Related]
10. Update on bacterial conjunctivitis in South Florida.
Cavuoto K; Zutshi D; Karp CL; Miller D; Feuer W
Ophthalmology; 2008 Jan; 115(1):51-6. PubMed ID: 17572497
[TBL] [Abstract][Full Text] [Related]
11. Contemporary antimicrobial activity of triple antibiotic ointment: a multiphased study of recent clinical isolates in the United States and Australia.
Jones RN; Li Q; Kohut B; Biedenbach DJ; Bell J; Turnidge JD
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):63-71. PubMed ID: 16368476
[TBL] [Abstract][Full Text] [Related]
12. Bacteriological pattern and their correlation with complications in culture positive cases of acute bacterial conjunctivitis in a tertiary care hospital of upper Assam: A cross sectional study.
Bhattacharyya A; Sarma P; Sarma B; Kumar S; Gogoi T; Kaur H; Prajapat M
Medicine (Baltimore); 2020 Feb; 99(7):e18570. PubMed ID: 32049777
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal conjunctivitis: microbiologic study and antibiotic sensitivity].
Martínez Ruiz MT; Ascaso Puyuelo FJ; Navales Bertol J; Palomar Gómez MT; García García C; Olivares López JL
An Esp Pediatr; 1993 Jul; 39(1):42-5. PubMed ID: 8363150
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops.
Jackson WB; Low DE; Dattani D; Whitsitt PF; Leeder RG; MacDougall R
Can J Ophthalmol; 2002 Jun; 37(4):228-37; discussion 237. PubMed ID: 12095096
[TBL] [Abstract][Full Text] [Related]
15. Non-gonococcal bacterial agents of conjunctivitis and their antibiotic susceptibility patterns in Ilorin, Nigeria.
Olatunji FO; Fadeyi A; Ayanniyi AA; Akanbi AA
Afr J Med Med Sci; 2007 Sep; 36(3):243-7. PubMed ID: 18390064
[TBL] [Abstract][Full Text] [Related]
16. [Bacterial conjunctivitis: most prevalent pathogens and their antibiotic sensitivity].
Orden Martínez B; Martínez Ruiz R; Millán Pérez R
An Pediatr (Barc); 2004 Jul; 61(1):32-6. PubMed ID: 15228931
[TBL] [Abstract][Full Text] [Related]
17. Management strategies for acute infective conjunctivitis in primary care: a systematic review.
Rose P
Expert Opin Pharmacother; 2007 Aug; 8(12):1903-21. PubMed ID: 17696792
[TBL] [Abstract][Full Text] [Related]
18. Spectrum and antibiotic susceptibility pattern of bacterial isolates from conjunctival swabs.
Malhotra S; Mehta DK; Kumar P
Indian J Pathol Microbiol; 2005 Oct; 48(4):538-41. PubMed ID: 16366121
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%.
Tabbara KF; El-Sheikh HF; Islam SM; Hammouda E
Eur J Ophthalmol; 1999; 9(4):269-75. PubMed ID: 10651190
[TBL] [Abstract][Full Text] [Related]
20. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study.
Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL
Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
